The Investor page website contains information about Opsens Inc. business for stockholders, potential investors, and financial analysts.


We welcome you to OpSens’ Investor Relations website and would like to thank you for your interest in our company. Through this website you can find comprehensive and detailed information about our IR activities and the performance of OpSens. Our website is especially tailored for institutional investors, analysts and private shareholders as well as anyone interested in OpSens’ financial performance.

Company Profile

OpSens focuses mainly on interventional cardiology. OpSens offers an advanced optical-based pressure guidewire, the OptoWire, that aims at improving the clinical outcome of patients with coronary artery disease and is currently introducing the SavvyWire as the world’s first and only sensor-guided TAVR solution. the SavvyWire uniquely provides a 3-in-1 solution for stable aortic valve delivery and positioning, continuous accurate hemodynamic measurement during the procedure, and reliable left ventricular pacing without the need for adjunct devices or venous access. OpSens is also involved in industrial activities in developing, manufacturing and installing innovative fibre optic sensing solutions for critical applications.

OpSens Annual Report_2022